Retatrutide (investigational) Retatrutide is the newest entrant, activating three receptors: GLP-1, GIP, and glucagon
In their younger reproductive years, womens ovaries have exhibited higher intracellular glutathione levels, and deficiency has been linked to premature ovarian ageing
Experimental rat models of DPN have identified early metabolic abnormalities affecting nerve conduction velocities and endoneurial blood flow [89]
Hims just held its Q2 earnings call, and well center the bulk of the conversation and controversy around them given the public availability of information along with the amount of discussion GLP-1s generated during the Q&A
Weight regain is common for patients who stop taking the medications, and benefits often fade within two years, early research has found
Mayo Clin Proc 2021;1996:744e62